November 17, 2014Open Access
View Full PaperAngiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
Key Points
Key points are not available for this paper at this time.
Abstract
http://www.clinicaltrials.gov. Unique identifier: NCT01035255.